haloperidol and nitrazepam

haloperidol has been researched along with nitrazepam in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19907 (33.33)18.7374
1990's2 (9.52)18.2507
2000's8 (38.10)29.6817
2010's4 (19.05)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA1
Abraham, MH; Acree, WE; Ibrahim, A1
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Deguchi, T; Matsui, Y1
Bansal, SK; Kumar, V; Patial, RK; Sharma, R1
Borsini, F; Lecci, A; Meli, A; Volterra, G1
Wambebe, C1
Fujii, T; Hayashi, K; Morimoto, S; Nakanishi, H; Ohtaki, Y; Yamamoto, N1
Marcy, R; Quermonne, MA1
Aoki, N; Moroji, T; Tada, K; Watanabe, N1
Delcros, M; Dreyfus, JF; Guelfi, JD; Pichot, P1
Aleem, HM1
Mitsunaga, H; Ukai, M1

Trials

1 trial(s) available for haloperidol and nitrazepam

ArticleYear
A double-blind controlled multicenter trial comparing butriptyline with amitriptyline.
    Neuropsychobiology, 1983, Volume: 9, Issue:2-3

    Topics: Adolescent; Adult; Aged; Amitriptyline; Clinical Trials as Topic; Dibenzocycloheptenes; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Middle Aged; Nitrazepam; Psychiatric Status Rating Scales

1983

Other Studies

20 other study(ies) available for haloperidol and nitrazepam

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:3

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations

2002
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
    European journal of medicinal chemistry, 2008, Volume: 43, Issue:3

    Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization

2008
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Cataleptic action of nitrazepam and brain dopamine function in mice.
    Neuropharmacology, 1977, Volume: 16, Issue:4

    Topics: Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Brain; Catalepsy; Chlorpromazine; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Fenclonine; Haloperidol; Humans; Male; Methyltyrosines; Mice; Nitrazepam; Norepinephrine; Phenobarbital; Receptors, Dopamine; Reflex; Reserpine; Serotonin

1977
Miosis with haloperidol.
    The Journal of the Association of Physicians of India, 1992, Volume: 40, Issue:1

    Topics: Adult; Haloperidol; Humans; Male; Miosis; Nitrazepam; Suicide, Attempted

1992
A model to measure anticipatory anxiety in mice?
    Psychopharmacology, 1989, Volume: 98, Issue:2

    Topics: Animals; Anxiety; Body Temperature; Diazepam; Haloperidol; Imipramine; Male; Mice; Models, Psychological; Motor Activity; Nitrazepam

1989
Influence of some dopaminoceptor agents on nitrazepam-induced sleep in the domestic fowl (Gallus domesticus) and rats.
    Japanese journal of pharmacology, 1986, Volume: 40, Issue:3

    Topics: Aminooxyacetic Acid; Animals; Apomorphine; Chickens; Dopamine; Dose-Response Relationship, Drug; Electroencephalography; Electromyography; Haloperidol; Levodopa; Male; Nitrazepam; Norepinephrine; Phentolamine; Pimozide; Rats; Receptors, Dopamine; Receptors, GABA-A; Sleep; Tetrahydronaphthalenes

1986
Alterations in the thermic response to chlorpromazine in rats exposed prenatally to central nervous system depressants.
    Neuropharmacology, 1986, Volume: 25, Issue:8

    Topics: Animals; Body Temperature; Central Nervous System Depressants; Chlorpromazine; Drug Interactions; Ethanol; Female; Haloperidol; Male; Nitrazepam; Phenobarbital; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Inbred Strains

1986
An improved method for studying the psychogalvanic reaction in mice and its inhibition by psycholeptic drugs. Comparison with the effects of other pharmacological agents.
    Psychopharmacologia, 1974, Feb-06, Volume: 34, Issue:4

    Topics: Adrenergic alpha-Antagonists; Animals; Benactyzine; Chlordiazepoxide; Chlorpromazine; Diazepam; Female; Galvanic Skin Response; Haloperidol; Hydroxyzine; Hypnotics and Sedatives; Male; Meprobamate; Methaqualone; Methotrimeprazine; Mice; Muscle Relaxants, Central; Neuromuscular Nondepolarizing Agents; Nitrazepam; Parasympatholytics; Pentobarbital; Phenobarbital; Phenothiazines; Thioridazine; Tranquilizing Agents; Trifluperidol

1974
A therapeutic trial of caerulein to a long-term heavy marihuana user with amotivational syndrome.
    Progress in neuro-psychopharmacology & biological psychiatry, 1984, Volume: 8, Issue:3

    Topics: Adult; Brief Psychiatric Rating Scale; Ceruletide; Drug Therapy, Combination; Haloperidol; Humans; Male; Marijuana Abuse; Motivation; Nitrazepam; Promethazine; Syndrome

1984
Haloperidol with nitrazepam poisoning.
    The Journal of the Association of Physicians of India, 1993, Volume: 41, Issue:4

    Topics: Haloperidol; Humans; Miosis; Nitrazepam

1993
Tail-swing behavior: a novel animal model for anxiety.
    Methods and findings in experimental and clinical pharmacology, 2003, Volume: 25, Issue:5

    Topics: Animals; Anxiety; Behavior, Animal; Desipramine; Diazepam; Disease Models, Animal; Haloperidol; Immobilization; Male; Mice; Muscle Tonus; Muscle, Skeletal; Nitrazepam; Psychotropic Drugs; Tail

2003